ULTRAGENYX PHARMACEUTICAL INC. Adjustments to Additional Paid in Capital, Warrant Issued
ULTRAGENYX PHARMACEUTICAL INC. (RARE) reported Adjustments to Additional Paid in Capital, Warrant Issued of $6.74 million for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-11.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2014-08-11
- ULTRAGENYX PHARMACEUTICAL INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2014-06-30 was $0.00.
- ULTRAGENYX PHARMACEUTICAL INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2014-03-31 was $6.74M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 47 month |
|---|---|---|---|
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $6.74M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $6.74M 10-Q · filed 2014-05-12 | $6.74M 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |